These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7658589)

  • 21. Nucleation at surfaces: the importance of interfacial energy.
    Wu W; Gerard DE; Nancollas GH
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S355-8. PubMed ID: 10541263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium oxalate crystal attachment to cultured kidney epithelial cell lines.
    Bigelow MW; Wiessner JH; Kleinman JG; Mandel NS
    J Urol; 1998 Oct; 160(4):1528-32. PubMed ID: 9751407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling influence of phosphocitrate in vitro and in vivo on calcium oxalate crystal formation and growth.
    Sallis JD; Parry NF; Meehan JD; Kamperman H; Anderson ME
    Scanning Microsc; 1995 Mar; 9(1):127-35; discussion 135-6. PubMed ID: 8553011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uric acid as inducer of calcium oxalate crystal development.
    Grases F; Sanchis P; Isern B; Perelló J; Costa-Bauzá A
    Scand J Urol Nephrol; 2007; 41(1):26-31. PubMed ID: 17366099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium oxalate crystal growth. A new constant composition method for modelling urinary stone formation.
    Sheehan ME; Nancollas GH
    Invest Urol; 1980 May; 17(6):446-50. PubMed ID: 7372431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system.
    Suzuki K; Tsugawa R
    Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps.
    Qiu SR; Wierzbicki A; Salter EA; Zepeda S; Orme CA; Hoyer JR; Nancollas GH; Cody AM; De Yoreo JJ
    J Am Chem Soc; 2005 Jun; 127(25):9036-44. PubMed ID: 15969581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of spherulites of calcium phosphate and crystallization of calcium oxalate in gel in a new experimental model of urinary stone formation.
    Achilles W; Jöckel U; Schaper A; Burk M; Ulshöfer B; Riedmiller H
    Investig Urol (Berl); 1994; 5():218-21. PubMed ID: 7719309
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents.
    Rodgers AL; Garside J
    Invest Urol; 1981 May; 18(8):484-8. PubMed ID: 7228583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of vinyl sulfonic acid homopolymer in calcium oxalate crystallization.
    Kirboğa S; Oner M
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):357-62. PubMed ID: 20400275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluation of calcium oxalate monohydrate crystals influenced by Costus igneus aqueous extract.
    Kesavan M; Kaliaperumal R; Tamilmani E; Shanmugam K
    Scand J Urol Nephrol; 2012 Aug; 46(4):290-7. PubMed ID: 22545945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
    Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
    Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.